Omep Uno (Omeprazole)

Omeprazole, the active ingredient in Omep Uno, is a Proton Pump Inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related conditions in adults and children. GNH USA supplies Omep Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omep Uno as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced gastropathy: helps prevent ulcer formation in at‑risk patients.

Omeprazole is generally well‑tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild, transient headache. - Diarrhea: loose stools, usually self‑limiting. - Abdominal pain: mild discomfort or cramping. - Nausea: occasional feeling of queasiness. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: kidney inflammation with reduced urine output. - Severe hypersensitivity: rash, angio‑edema, or anaphylaxis. - Osteoporotic fractures: increased risk of hip, spine or wrist fractures with long‑term use. - Vitamin B12 deficiency: reduced absorption leading to anemia. - Hepatotoxicity: elevated liver enzymes or hepatitis.

When prescribing Omeprazole, clinicians should consider several safety aspects.

- Assess renal function: adjust use in severe renal impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term use: evaluate need for continued therapy after several months. - Pregnancy and lactation: weigh benefits against potential risks. - Elderly patients: start with the lowest effective dose and monitor. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduces the antiplatelet effect . - Atorvastatin: increased plasma concentration may raise risk of myopathy. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: higher serum levels possible. - Methotrexate: reduced renal clearance may increase toxicity. - Phenytoin: altered metabolism may affect seizure control. - Ketoconazole: decreased absorption due to higher gastric pH. - Iron‑relevant